Learn more

LEIBNIZ INST NATURSTOFF FORSCH

Overview
  • Total Patents
    34
About

LEIBNIZ INST NATURSTOFF FORSCH has a total of 34 patent applications. Its first patent ever was published in 2005. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and Germany. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are HOECHST INDIA, INST BIOMAR SA and PRIZER PRODUCTS INC.

Patent filings per year

Chart showing LEIBNIZ INST NATURSTOFF FORSCHs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Hertweck Christian 19
#2 Moellmann Ute 10
#3 Herold Kerstin 9
#4 Siering Armin 8
#5 Ozegowski Joerg-Hermann 8
#6 Horn Uwe 7
#7 Bardl Bettina 7
#8 Mueller Peter-Juergen 7
#9 Scherlach Kirstin 7
#10 Peschel Gundela 6

Latest patents

Publication Filing date Title
WO2014032782A1 Jagaricin derivatives and their use as fungicide or antitumor agent
WO2014029498A1 Bixiamycins and sulfonylbixiamycins
WO2014019685A1 Novel chartreusin analogues
EP2726487A1 Benzopyranobenzothiazinones and their use as fungicides, antibiotics and antitumor agents
WO2010034514A2 Cfhr1 as a c5 convertase inhibitor for the treatment of autoimmune diseases
EP2230235A1 Botryosphaerones, novel depsidones and their use as medicaments
EP2108650A1 Novel aureothin derivatives
DE102007035323A1 New diazen-1-ium-1,2-diolate substituted ketoconazole derivatives are ergosterol biosynthesis inhibitors useful as an active agent against microbial pathogenic germs, e.g. fungus, and an antiinflammatory active agent
EP2020406A1 New antimicrobial compounds, their synthesis and their use for treatment of mammalian infection
DE102007010866A1 Device for immersing microcultivation and investigation of growth, morphology, and metabolism of microorganisms or cells, comprises tension-free unidimensional element and nutrient for growth of microorganisms or cells
EP1932526A1 Morin, a new inhibitor of microbial hyaluronate lyase
EP1940848A1 Antimitotic rhizoxin derivatives of burkholderia rhizoxina, method for producing said derivatives and use thereof
EP1908754A1 Antibiotic maduraphthalazin salts with delayed release of the active substance and their use
EP2029583A1 New benzothiazinone derivatives and their use as antibacterial agents
DE102006006893B3 New aspoquinolone compounds useful in the preparation of anti-proliferative therapeutics
DE102005053670A1 Process for the cleavage of cervimycin half-esters
DE102005052338A1 Preparation of aliphatic dicarboxylic acid, preferably methyl malonic acid and/or dimethyl malonic acid, useful e.g. in chemical industry for the production of polyester, comprises fermentation of a microorganism culture
DE102005034590A1 Fermentative production of methyl- and dimethyl-malonic acids, useful particularly for preparing polyesters, comprises growing Streptomyces
DE102005026417B3 Producing rhizoxin and/or rhizoxin derivatives potentially useful as antitumor agents comprises culturing Burkholderia rhizoxina